Clinical and Medicinal Chemistry
Clinical and medicinal chemistry news, blogs, and links
HAMBURG, Germany and ABINGDON, UK, Dec. 14, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that it has received a milestone payment from Ono Pharmaceutical Co., Ltd. (Ono) from its research collaboration aimed at identifying novel inhibitors for a protease target. The milestone is received for the progression of the medicinal chemistry collaboration into lead optimisation. The programme success validates again the...
More perspectives...
From globenewswire.com
()
= = - Evotec receives milestone from Ono for the progression of novel protease inhibitors into lead optimisation - Hamburg, Germany / Abingdon, UK - 14 December 2009: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX) today announced that it has received a
More perspectives...
From ad-hoc-news.de
()
Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. - Evotec receives milestone from Ono for the progression of novel protease inhibitors into lead o
More perspectives...
From finanztreff.de
()
Evotec extends its research collaboration with Ono to include an ion channel target - - Hamburg, Germany - Evotec AG (Frankfurt Stock Exchange: EVT; NASDAQ: EVTC) today announced that it has extended ...
More perspectives...
From webwire.com
()
HAMBURG, Germany, Oct. 15, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC) today announced that it has extended its current research collaboration with Ono Pharmaceutical Co., Ltd. (Ono) and initiated a new discovery collaboration. Under the contract extension Evotec will provide integrated drug discovery activities, including high throughput screening, medicinal chemistry and in vitro pharmacology to discover novel, small...
More perspectives...
From globenewswire.com
()

